Another study showed that changes in the levels of miR-25, GDF-15, and CA19-9 made accurate discrimination possible and that the plasma levels of the six miRNAs and MIC-1, CA19-9 were elevated in pancreatic cancer patients compared with those of healthy controls [263]. Here, GDF15 is linked to pancreatic neoplasm.